Trxade Group Inc (MEDS) Financials

$0.88

$-0.01 (-1.18%)

As on 11-Sep-2026 13:19EDT

Market cap

$3 Mln

Revenue (TTM)

$8 Mln

P/E Ratio

--

P/B Ratio

1.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	8.02	23.34	18.13	--	32.78	9.89
Cost of Revenue	18.06	32.98	16.36	--	27.03	5.14
Gross Profit	-10.04	-9.64	1.77	--	5.75	4.75
Operating Expenses	47.67	71.56	7.91	2.88	9.17	8.81
Operating Profit (EBIT)	-57.71	-81.19	-6.15	-2.88	-3.42	-5.29
Other Income	--	--	--	--	--	--
Profit before Tax	-88.28	-101.27	-6.86	-2.90	-2.74	-5.32
Provision for Tax	--	--	--	--	--	-1.20
Profit after Tax (Net Income)	-88.28	-101.27	-6.86	-2.90	-2.74	-4.11
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-5.32

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-19.50	-12.45	6.73	-2.90	-0.01	3.77
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	12.85	13.13	12.55	0.35	--	1.07
Current Liabilities	39.41	29.78	38.05	2.89	0.01	0.93
Total Liabilities	72.17	30.46	57.33	0.34	--	5.77

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	27.13	27.64	42.16	--	--	1.39
Current Assets	5.63	2.82	15.17	0.34	--	4.37
Total Assets	38.39	30.46	57.33	0.34	--	5.77
Total Debt*	32.62	24.77	25.11	0.70	--	1.25
Net Current Assets	--	-26.96	-22.88	-2.55	-0.01	3.45

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-10.86	-1.22	-0.35	--	-2.57
Cash Flow from Investing Activities	--	-0.88	0.47	--	--	-0.02
Cash from Financing Activities	--	10.75	1.78	0.35	--	-0.21
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-53.52	-71.34	-6.60	-3.09	--	--
Cash EPS ($)	--	-69.07	-5.53	-3.09	--	--
Adjusted Book Value ($)	--	--	6.48	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-7.65	-1.18	-0.37	--	--
Free Cash Flow per Share ($)	--	-7.65	-1.54	-0.37	--	--

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-458.64	-46.26	262.57	-109.46	-57.42
ROE (%)	--	3,545.19	-357.65	199.31	-145.76	-66.08
ROA (%)	-130.76	-230.71	-23.78	-1,711.58	-95.17	-52.87
EBIT Margin (%)	-732.02	-414.33	-33.23	--	-7.49	-53.51
Net Margin (%)	-1,100.30	-433.95	-37.82	--	-8.37	-41.59
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-56.41	0.29	--	-1.00	2.31	-0.42
EBIT Growth (%)	-48.65	-1,504.96	--	--	53.58	-102.83
Net Profit Growth (%)	-111.18	-1,377.12	-136.77	-5.54	33.29	-60.33
EPS Growth (%)	-36.42	-9.81	-1.13	--	--	--
Book Value Growth (%)	-1,133.81	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	--	--	-1.68	--	--
Price / Book Value	1.81	--	--	-1.68	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	--	--	-1.93	--	0.36
Close Price ($)	--	--	--	5.20	6.04	35.40
High Price ($)	--	--	--	19.70	52.05	162.30
Low Price ($)	--	--	--	3.77	4.21	33.60
Market Cap ($ Cr)	2.80	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-1.99	3.73	-0.24	--	0.33
Short term debt to equity ratio	-1.01	-0.94	1.86	-0.12	--	0.09
Current Ratio	0.14	0.09	0.40	0.12	--	4.72
Quick Ratio	0.10	0.04	0.15	0.12	--	4.66
Interest Coverage	-13.87	-21.11	-7.25	--	-8.55	-224.34

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	14.96	4.87	20.66	--	--	9.90
Asset Turnover	0.12	0.53	0.63	--	11.37	1.27
Receivable days	--	38.21	41.13	--	10.91	53.03
Inventory Days	--	61.80	106.25	--	0.76	46.66
Payable days	--	99.83	82.30	--	3.26	26.06
Cash Conversion Cycle	--	0.18	65.08	--	8.41	73.63

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.